New Type 2 Diabetes: The First-Visit Workflow

The first visit after a new type 2 diabetes diagnosis

The first visit after a new type 2 diabetes diagnosis has one job: confirm the diagnosis, get the baseline labs that will actually change treatment, start one medication the patient can realistically take, and set a follow-up window. You do not need to solve diabetes in a 15-minute visit. You need to leave the patient with a plan and yourself with a clear next step.

Here is the order that keeps a new-diagnosis visit from running long or missing something.

Step 1: confirm the diagnosis

If the diagnosis came from a single abnormal test (a random glucose, one A1c, one fasting glucose), current guidance still calls for confirmation with a second test, either a repeat of the same test or a different one, unless the patient has clear symptoms of hyperglycemia and the result isn't in question. Do not skip this step just because a value looked convincing.

Step 2: get the baseline labs that change the plan

Order labs that inform the medication choice and the complication screen, not a reflexive full panel:

• A1c (if not already done) to confirm severity and set the target
• Comprehensive metabolic panel for renal function, since kidney function shapes medication choice
• Urine albumin-to-creatinine ratio for baseline kidney screening
• Lipid panel for cardiovascular risk
• Liver panel if starting a medication that requires it

These are the tests that actually shape what you prescribe and what you screen for next, not busywork.

Step 3: pick a starting medication using a person-centered lens, not a default

Current guidance has moved away from "start metformin for everyone." The first medication now gets matched to the patient's cardiovascular history, kidney function, weight goals, and what they can actually afford or access, and that matching has real organ-protective consequences beyond glucose lowering. Metformin is still a reasonable, well-tolerated starting point for a lot of patients, but it is a starting point you choose, not a default you skip past thinking.

The point is not to memorize every algorithm branch. It is to ask three questions before you write the prescription: does this patient have cardiovascular disease or heart failure, does this patient have kidney disease, and what can this patient actually afford and tolerate. Working through those three questions and landing on the right agent, especially when a patient has more than one of them pulling in different directions, is exactly the kind of decision I walk through step by step inside Mastery.

Step 4: teach one thing well, not everything at once

A new diagnosis visit is not the visit to cover carb counting, every complication, and a full nutrition consult. Pick the two or three things that matter most right now:

• What the diagnosis means in plain language
• What the new medication does and the most common side effect to expect
• What "checking in" will look like (repeat labs, follow-up visit timing)

Everything else, referrals to diabetes education, ophthalmology, dietary counseling, can be queued for the follow-up rather than crammed into visit one.

Step 5: set the follow-up window

A1c reflects roughly the prior three months, so recheck it around the three-month mark to see if the plan is working. Some medication choices need a closer check-in before that lab recheck to confirm tolerance and safety, and knowing which ones do (and how soon) is part of the prescribing decision itself, not an afterthought.

When to escalate beyond primary care

Frequently asked questions

Do I need to confirm a new type 2 diabetes diagnosis with a second test?
Yes, unless the patient has clear hyperglycemia symptoms and the result isn't in question. A single abnormal test should be confirmed with a repeat of the same test or a different diagnostic test before you finalize the diagnosis.

Is metformin still the default first medication for new type 2 diabetes?
Not automatically. Current guidance favors matching the first medication to the patient's cardiovascular and kidney risk rather than starting the same drug for everyone. Metformin remains a reasonable choice for a lot of patients, but which agent goes first should be a deliberate call, not a reflex.

What labs are essential at the first type 2 diabetes visit?
A1c, a comprehensive metabolic panel, a urine albumin-to-creatinine ratio, and a lipid panel. These directly inform medication choice and baseline complication screening rather than being a routine catch-all panel.

How much should I teach at the first visit after a new diabetes diagnosis?
Focus on what the diagnosis means, what the new medication does, and what follow-up will look like. Diabetes education, ophthalmology, and detailed nutrition counseling can be queued for the follow-up visit instead of covered all at once.

When should I bring a newly diagnosed patient back for follow-up?
Recheck A1c around the three-month mark to assess whether the plan is working. Some medication choices call for a closer check-in before then, and which ones do is part of the prescribing decision itself.

Written by Allison Sowders, MSN, APRN, FNP-BC, a practicing primary care nurse practitioner and founder of Nurse Practitioner Mentor. Reviewed July 2026.

Once the first visit is handled, the medication titration and follow-up visits are their own decision points. See Starting Basal Insulin and Clinical Pearls for Prescribing Insulin for what comes next. Inside the Primary Care Clinical Mastery Program the full diabetes management pathway, from diagnosis through insulin titration, is taught as one connected system, with CE hours included. Want a faster reference for the visit itself? The Clinical Desk Reference gives you one-page answers for the labs and visits you see most.